Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Non-small Cell Lung Cancer Metastatic × AZD 8931 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 3 Neoplasm Metastasis 2 Breast Neoplasms 2 Non-small Cell Lung Cancer Metastatic 1 Colorectal Neoplasms 1

Interventions

1-(1-(imidazo(1,2-a)pyridin-6-yl)ethyl)-6-(1-methyl-1H-pyrazol-4-yl)-1H-(1,2,3)triazolo(4,5-b)pyrazine 2 vistusertib 1 vandetanib 1 telomerase reverse transcriptase p572Y, human 1 spartalizumab 1 pembrolizumab 1 olaparib 1 durvalumab 1 capivasertib 1 Vinorelbine 1 Ramucirumab 1 Pemetrexed 1 Paclitaxel 1 Gemcitabine 1 Erlotinib Hydrochloride 1 Docetaxel 1 Carboplatin 1 Bevacizumab 1 AZD4547 1 AZD 8931 1 AZD 6244 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02117167 2024-01-10

SAFIR02_Lung

UNICANCER

Phase 2 Completed

Non-small Cell Lung Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡